4967.T
4967.T
JP3301100008
KOBAYASHI PHARMACEUTICALS
Loading chart...

Financials

Trends
* Timeframes marked with (Est.) are analyst estimates based on consensus data.
Details
Breakdown 2025 2024 Change %
Total Revenue 165.742.000.000 165.600.000.000
0.1%
Cost of Revenue 81.030.000.000 77.997.000.000
3.9%
Gross Profit 84.711.000.000 87.603.000.000
3.3%
69.783.000.000 62.734.000.000
11.2%
Operating Income 14.928.000.000 24.869.000.000
40.0%
Pretax Income 3.744.000.000 13.914.000.000
73.1%
Net Income Common Stockholders 3.656.000.000 10.067.000.000
63.7%
-- --
--
-- --
--
ende